Clinical data | |
---|---|
Trade names | Largactil, Thorazine, many others |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682040 |
License data |
|
Pregnancy category |
|
Routes of administration | Oral (tablets and syrup available), rectal, IM, IV infusion |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 10–80% (Oral; large interindividual variation)[1] |
Protein binding | 90–99%[1] |
Metabolism | Liver, mostly CYP2D6-mediated[1] |
Elimination half-life | 30 hours |
Excretion | Urine (43–65% in 24 hrs)[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.000.042 |
Chemical and physical data | |
Formula | C17H19ClN2S |
Molar mass | 318.86 g/mol (free base) 355.33 g/mol (hydrochloride) |
3D model (JSmol) | |
| |
| |
(verify) |
Chlorpromazine, also known by its trade name Thorazine, is an antipsychotic drug. It is typically used to treat Schizophrenia. It has also been used to treat bipolar disorder. It has been shown to help uncontrollable hiccups disappear. It is also used to help with nausea and vomiting.[2] Chlorpromazine was developed in 1950, making it the oldest antipsychotic drug.[3]